Phospho-EGFR (Tyr845) Polyclonal Antibody, RBITC Conjugated, Rabbit

Artikelnummer: BSS-BS-3111R-RBITC
Artikelname: Phospho-EGFR (Tyr845) Polyclonal Antibody, RBITC Conjugated, Rabbit
Artikelnummer: BSS-BS-3111R-RBITC
Hersteller Artikelnummer: bs-3111R-RBITC
Alternativnummer: BSS-BS-3111R-RBITC-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: FC, WB
Spezies Reaktivität: Human
Konjugation: RBITC
Alternative Synonym: Epidermal growth factor receptor, p170EGFR, ERBB1, HER1, Avian erythroblastic leukemia viral verbb oncogene homolog, EGF R, EGFR, erbb 1, Erbb, Erbb1, mENA, Oncogene ERBB, Receptor tyrosine protein kinase ErbB1, Urogastrone, wa2, Wa5
Protein kinases are enzymes that transfer a phosphate group from a phosphate donor onto an acceptor amino acid in a substrate protein. By this basic mechanism, protein kinases mediate most of the signal transduction in eukaryotic cells, regulating cellular metabolism, transcription, cell cycle progression, cytoskeletal rearrangement and cell movement, apoptosis, and differentiation. The protein kinase family is one of the largest families of proteins in eukaryotes, classified in 8 major groups based on sequence comparison of their tyrosine (PTK) or serine/threonine (STK) kinase catalytic domains. Epidermal Growth factor receptor (EGFR) is the prototype member of the type 1 receptor tyrosine kinases. EGFR overexpression in tumors indicates poor prognosis and is observed in tumors of the head and neck, brain, bladder, stomach, breast, lung, endometrium, cervix, vulva, ovary, esophagus, stomach and in squamous cell carcinoma.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 1956
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic phosphopeptide derived from human EGFR around the phosphorylation site of Tyr845
Target-Kategorie: Phospho-EGFR (Tyr845)
Application Verdünnung: WB(1:300-5000), FCM(1:20-100)